Author: Yang Xu; Yi-rong Li; Qiang Zeng; Zhi-bing Lu; Yong-zhe Li; Wei Wu; Sheng-yong Dong; Gang Huang; Xing-huan Wang
Title: Clinical Characteristics of SARS-CoV-2 Pneumonia Compared to Controls in Chinese Han Population Document date: 2020_3_10
ID: glq0lckz_32
Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.08.20031658 doi: medRxiv preprint 11 antibiotics. The antibiotics used generally covered mild pathogens and some atypical pathogens; when secondary bacterial infection occurred, medication was administered according to the results of bacterial culture and drug sensitivity. The antibiotics used were moxifloxacin, ceftriaxone, azithromycin,.....
Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.08.20031658 doi: medRxiv preprint 11 antibiotics. The antibiotics used generally covered mild pathogens and some atypical pathogens; when secondary bacterial infection occurred, medication was administered according to the results of bacterial culture and drug sensitivity. The antibiotics used were moxifloxacin, ceftriaxone, azithromycin, and tigecycline or linezolid against methicillin-resistant Staphylococcus aureus, as well as antifungal drugs. Six patients significantly increased in IL6 were also treated with methylprednisolone. Three patients used non-invasive ventilator mechanical ventilation. Two patients used an invasive ventilator to assist ventilation. The ventilator adopted P-SIMV mode, the inhaled oxygen concentration was 35-100%, and the positive end-expiratory pressure was 6-12 cm H 2 O. No patients were treated with extracorporeal membrane oxygenation (ECMO). Moreover, 7.3% patients were diagnosed ARDS, 7.3% patients were diagnosed acute cardiac injury (troponin I>28 pg/mL) and 4.4% patients were diagnosed fungal infections or shock (Table 1) .
Search related documents:
Co phrase search for related documents- acute cardiac injury and cardiac injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute cardiac injury and ECMO extracorporeal membrane oxygenation: 1, 2, 3, 4, 5, 6
- acute cardiac injury and extracorporeal membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute cardiac injury and fungal infection: 1
- antifungal drug and fungal infection: 1, 2, 3, 4
- atypical pathogen and bacterial infection: 1, 2, 3
- atypical pathogen and extracorporeal membrane oxygenation: 1
- bacterial culture and fungal infection: 1, 2, 3, 4, 5
- bacterial infection and cardiac injury: 1, 2
- bacterial infection and ECMO extracorporeal membrane oxygenation: 1, 2, 3, 4, 5, 6, 7
- bacterial infection and extracorporeal membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- bacterial infection and fungal infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cardiac injury and ECMO extracorporeal membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8
- cardiac injury and end expiratory: 1
- cardiac injury and end expiratory pressure: 1
- cardiac injury and extracorporeal membrane oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- cardiac injury and fungal infection: 1
- drug sensitivity and ECMO extracorporeal membrane oxygenation: 1
- drug sensitivity and end expiratory: 1
Co phrase search for related documents, hyperlinks ordered by date